David Steensma, Author at Cancer Therapy Advisor

David Steensma

All articles by David Steensma

Myelodysplastic Syndromes

Myelodysplastic syndromes What every physician needs to know: The myelodysplastic syndromes (MDS) include a heterogeneous group of clonal bone marrow failure syndromes characterized by cytopenias, clonally restricted hematopoiesis (associated with an abnormal G-banded metaphase karyotype in about 50% of cases), genomic instability, and a risk of progression to acute myeloid leukemia (AML). More than 85%…

Next post in Hospital Medicine